Kilitch Drugs (India) Ltd
KILITCH
Company Profile
Business description
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in operation and management of Pharmaceutical Products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, and HPURE. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.
Contact
Waman Tukaram Patil Marg
37/39, Ujagar Industrial Estate
Deonar
MumbaiMH400 088
INDT: +91 2261214100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
187
Stocks News & Analysis
stocks
ASX listed gold miner under pressure due to lower production
Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks
3 ASX opportunities after earnings season
Uncovering key opportunities following February’s results.
stocks
Oracle earnings: Solid execution secures revenue target and mitigates investor concerns
We raise our fair value estimate for Oracle stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,819.40 | 9.30 | -0.11% |
| CAC 40 | 7,974.49 | 38.52 | 0.49% |
| DAX 40 | 23,730.92 | 166.91 | 0.71% |
| Dow JONES (US) | 47,093.49 | 147.08 | 0.31% |
| FTSE 100 | 10,403.60 | 85.91 | 0.83% |
| HKSE | 25,868.54 | 34.52 | 0.13% |
| NASDAQ | 22,490.88 | 116.71 | 0.52% |
| Nikkei 225 | 53,700.39 | 50.76 | -0.09% |
| NZX 50 Index | 13,182.23 | 17.65 | 0.13% |
| S&P 500 | 6,726.52 | 27.14 | 0.41% |
| S&P/ASX 200 | 8,614.30 | 4.40 | -0.05% |
| SSE Composite Index | 4,049.91 | 34.88 | -0.85% |